These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37868230)

  • 1. Anaphylaxis to Lumason Contrast Agent in Echocardiography after Immune Sensitization: A Case Report and Literature Review.
    Mikhail ES; Ghaly JB; Malik B; Ghatol AG
    J Community Hosp Intern Med Perspect; 2023; 13(4):74-78. PubMed ID: 37868230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case Report of Cardiac Arrest After Intravenous Administration of Sulfur Hexafluoride (Lumason
    Arnouk S; Huynh Q; Saric M; Papadopoulos J
    J Pharm Pract; 2024 Apr; 37(2):509-512. PubMed ID: 36803045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
    Seitz K; Strobel D
    Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Lumason® (SonoVue®) in special populations and critically ill patients.
    Filippone A; Kirchin MA; Monteith J; Storto ML; Spinazzi A
    Front Cardiovasc Med; 2023; 10():1225654. PubMed ID: 37600063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety profile of ultrasound enhancing agents in echocardiography.
    Kumar S; Purtell C; Peterson A; Gibbons P; Khan AM; Heitner SB
    Echocardiography; 2019 Jun; 36(6):1041-1044. PubMed ID: 31038768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Lumason Contrast Echocardiography in Post-myocardial Infarction Ventricular Septal Defect.
    Cinelli M; Karam B; Spagnola J; Assaad M; Salmane C; Hoyek W; Schwartz C
    Cureus; 2022 Jul; 14(7):e27128. PubMed ID: 36004020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare case of echo enhancing agent anaphylaxis complicated by acute coronary syndrome.
    Steinhauer R; Miyashita S; Chweich H; Ortoleva J; Downey BC
    Echocardiography; 2023 Jul; 40(7):743-746. PubMed ID: 37204062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylactic reaction to an ultrasound contrast agent (Lumason) in a patient with systemic mastocytosis.
    Olson MC; Atwell TD; Knudsen JM
    J Clin Ultrasound; 2018 Oct; 46(8):533-535. PubMed ID: 29517164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast enhanced ultrasound for focal liver lesions: how accurate is it?
    Barr RG
    Abdom Radiol (NY); 2018 May; 43(5):1128-1133. PubMed ID: 28718042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice.
    Ali MT; Johnson M; Irwin T; Henry S; Sugeng L; Kansal S; Allison TG; Bremer ML; Jones VR; Martineau MD; Wong C; Marecki G; Stebbins J; Michelena HI; McCully RB; Svatikova A; Padang R; Scott CG; Kanuga MJ; Arsanjani R; Pellikka PA; Kane GC; Thaden JJ
    J Am Soc Echocardiogr; 2024 Mar; 37(3):276-284.e3. PubMed ID: 37879379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhanced ultrasound characterization of surgically resected renal masses in patients on dialysis.
    Kahn AE; Ostrowski AK; Caserta MP; Galler IJ; Thiel DD
    Scand J Urol; 2019 Oct; 53(5):344-349. PubMed ID: 31549563
    [No Abstract]   [Full Text] [Related]  

  • 12. Pediatric contrast-enhanced ultrasound: shedding light on the pursuit of approval in the United States.
    Darge K; Back SJ; Bulas DI; Feinstein SB; Ntoulia A; Volberg FM; Wilson SR; McCarville MB
    Pediatr Radiol; 2021 Nov; 51(12):2128-2138. PubMed ID: 34117520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety Analysis of Adverse Events of Ultrasound Contrast Agent Lumason/SonoVue in 49,100 Patients.
    Li Q; Yang K; Ji Y; Liu H; Fei X; Zhang Y; Li J; Luo Y
    Ultrasound Med Biol; 2023 Feb; 49(2):454-459. PubMed ID: 36357252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylactic shock with an ultrasound contrast agent.
    Coudray S; Fabre C; Aichoun I; Perez-Martin A
    J Med Vasc; 2017 Dec; 42(6):384-387. PubMed ID: 29203045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of lumason/sonovue in contrast-enhanced ultrasound of the kidney for characterization of renal masses-a meta-analysis.
    Barr RG
    Abdom Radiol (NY); 2022 Jan; 47(1):272-287. PubMed ID: 34623494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Implementing Contrast-Enhanced Ultrasound for Antegrade Nephrostogram After Percutaneous Nephrolithotomy.
    Fetzer DT; Flanagan J; Nabhan A; Pongsatianwong K; Antonelli J; Pearle M; Vijay K; Watumull L
    J Ultrasound Med; 2021 Jan; 40(1):101-111. PubMed ID: 32639063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-Enhanced Ultrasound and Shear Wave Elastography: Novel Methods for the Evaluation of Urethral Stricture Disease.
    Chung PH; Leong JY; Machado P; Wessner CE; Trabulsi EJ; Halpern EJ; Eisenbrey JR; Forsberg F
    J Urol; 2022 Jan; 207(1):152-160. PubMed ID: 34428090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic Mapping with Contrast-enhanced Ultrasound for Lymphaticovenous Anastomosis Surgery: How We Do It.
    Jang S; Bustos SS; Chen AD; Zheng EE; Hesley GK; Brinkman NJ; Carter JS; Tran NV; Fahradyan V; Lee CU
    Plast Reconstr Surg Glob Open; 2023 Oct; 11(10):e5328. PubMed ID: 37842077
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.